Design and Evaluation of Nifedipine-Loaded Liposomal Nanocarriers for Enhanced Drug Delivery and Sustained Antihypertensive Therapy
International Journal of Drug Delivery Technology · 16.04.2026 · 16 (13s)
DOI: 10.25258/ijddt.16.13s.115 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 16.04.2026. Verfasst von Dr. A. Venkata Badarinath und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Hypertension is the most prevalent contributor of cardiovascular morbidity and mortality around the world that requires finding new drug delivery techniques to enhance therapeutic outcomes. Nifedipine, which is commonly used as a calcium channel blocker, is associated with its impairments in terms of low aqueous solubility, high first-pass metabolism, and low half-life, thereby causing inadequate bioavailability. The aim of the current research was to prepare and encapsulate nifedipine in liposomal nanocarriers to increase the drug delivery efficiency and release properties. Nifedipine-filled liposomes were prepared by the ethanol injection procedure where soya lecithin and cholesterol spliced into the lipids. Preformulation tests such as solubility, constructing a calibration curve, and Fourier Transform Infrared (FTIR) spectroscopy assay helped in determining the drug identity and its solubility and compatibility with excipients. The studies implemented on Franz diffusion described the following characteristics of formulations: particle size, polydispersity index (PDI), zeta potential, entrapment efficiency, and in vitro drug release. Out of the developed formulations (F1-F17), formulation F11 was the best with a particle size of 243.4 nm, PDI of 0.381, zeta potential of ─39.8 mV, and entrapment efficiency of 85.92%. The shape had a sustained drug release (75.8% in 12 hours), which is a sign of diffusion behavioral control. FTIR analysis showed no evidence of chemical interactions, promoting the stability of the formulation. The study proves that liposomal encapsulation does help in enhancing the delivery of nifedipine, which is a promising method of improved hypertension treatment due to the ability to provide a longer and prolonged therapeutic effect to the patient and lower the dosage frequency rate.
Zitieren
APA
Badarinath, D. A. V., Ugandar, D. R., Rao, S. S., & Obaiah, P. (2026). Design and Evaluation of Nifedipine-Loaded Liposomal Nanocarriers for Enhanced Drug Delivery and Sustained Antihypertensive Therapy. International Journal of Drug Delivery Technology, 16(13s). https://doi.org/10.25258/ijddt.16.13s.115
Vancouver
Badarinath DAV, Ugandar DR, Rao SS, Obaiah P. Design and Evaluation of Nifedipine-Loaded Liposomal Nanocarriers for Enhanced Drug Delivery and Sustained Antihypertensive Therapy. International Journal of Drug Delivery Technology. 2026;16(13s). doi:10.25258/ijddt.16.13s.115
BibTeX
@article{Badarinath2026,
author = {Badarinath, Dr. A. Venkata and Ugandar, Dr. R.E. and Rao, S. Subramanyam and Obaiah, Pabbati},
title = {Design and Evaluation of Nifedipine-Loaded Liposomal Nanocarriers for Enhanced Drug Delivery and Sustained Antihypertensive Therapy},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {13s},
doi = {10.25258/ijddt.16.13s.115}
}
EUVIMED